Article Sidebar

Submitted
Oct 18, 2022
Accepted
Jan 27, 2023
Published
Mar 1, 2023
Download
PDF
Statistic
Read Counter : 434 Download : 487

Main Article Content

Abstract

Background: The pandemic Covid-19 has had an impact on various aspects of life, both socially and economically. One of the government's responsibilities is in financing the treatment of Covid-19 patients, which is stated in the Decree of the Minister of Health of the Republic of Indonesia Number HK.01.07/MENKES/5673/2021 regarding technical instructions for claiming the cost of Covid-19 services. Objectives: This study aimed to determine the average direct medical costs and according to the INA-CBGs rates for Covid-19 patients and the effect of length of stay, severity and comorbidities on the total cost from a hospital perspective. Material and Methods: This study was an observational descriptive study, used a sample of patients diagnosed with Covid-19 inpatients at Anutapura Hospital Palu in 2020. The sample was used 134 patients, who met the inclusion and exclusion criteria. The data collected includes patient characteristics, direct medical costs (consultation fees, visits, rooms, medical procedures, medical devices, examinations and drugs) and INA-CBGS rates. Results: the Covid-19 patients were hospitalized for 14 days (65.67%) with severe severity (92.54%), patients without comorbidities (comorbidities) (74.63%) and included in the group with INA-CBGs code was A-4-13-III (92.54%). The average direct medical cost of the patient was Rp. 5,371,333, with the largest cost being the room fee, which was 32.57% of the total cost. The average INA-CBG's tariff was Rp. 123,019,851.  Conclusions: The INA-CBGs tariff was higher than direct medical costs with a difference of Rp. 117,648,518. The results of the linear regression test, it was found that there was a partial or simultaneous effect between length of hospitalization, severity and incidence of comorbidities on total direct medical costs.

Keywords

COVID-19 Direct medical cost INA-CBG's rates

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Author Biography

Muhamad Rinaldhi Tandah, Jurusan Farmasi, Fakultas Matematika dan Ilmu Pengetahuan Alam, Universitas Tadulako, Palu, Indonesia.

Lecturer of Pharmacoeconomy, Management of Pharmacy, and Pharmacokinetics Department of Pharmacology and Clinical Pharmacy, Faculty of Mathematics and Natural Sciences, Tadulako University

How to Cite
Tandah, M. R., Diana, K., Adisaputra, A. D., Monica, S., & Azzahrah, F. (2023). Direct Medical Costs and Accordance of INA-CBG’s Claims on Covid-19 Patients at Anutapura Hospital: Biaya Medis Langsung dan Kesesuaian Klaim Tarif INA-CBG’s pada Pasien Covid-19 di RSU Anutapura. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal), 9(1), 71-83. https://doi.org/10.22487/j24428744.2023.v9.i1.16073

References

  1. Alon, T., Doepke, M., Rumsey, J. O., & Tertilt, M. (2020). The Impact of Covid-19 on Gender Equality. Nber working paper series. https://doi.org/10.1007/s10272-021-0992-7
  2. Ambarwati, W. (2021). Pembiayaan Pasien Covid-19 dan Dampak Keuangan terhadap Rumah Sakit yang Melayani Pasien Covid-19 di Indonesia Analisis Periode Maret 2020 – Desember 2020. Jurnal Ekonomi Kesehatan Indonesia, 6(1), 23–37. https://doi.org/10.7454/eki.v6i1.4881
  3. Arief, I., Sumarny, R., Sumiyati, Y., & Kusuma, I. (2021). Hubungan Karakteristik Klinik dan Profil Pengobatan dengan Parameter Hematologi dan Lama Rawat Pasien Covid-19 di Rumah Sakit Yarsi Jakarta. Journal Ilmiah Indonesia, 6(11), 1–14.
  4. Badan Pusat Statistik. (2020). Hasil Survei Sosial Demografi Dampak Covid-19. In Badan Pusat Statistik. BPS RI.
  5. Budiarto, W., & Sugiharto, M. (2013). Biaya Klaim INA CBGs dan Biaya Riil Penyakit Katastropik Rawat Inap Peserta Jamkesmas di Rumah Sakit Studi di 10 Rumah Sakit Milik Kementrian Kesehatan Januari-Maret 2012. Buletin Penelitian Sistem Kesehatan, Volume 16(1), 58–65.
  6. Dinas Kesehatan Provinsi Sulawesi Tengah. (2019). Profil Kesehatan Tahun 2019.
  7. Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020). Impact of sex and gender on Covid-19 outcomes in Europe. Biology of Sex Differences, 11(1), 1–13. https://doi.org/10.1186/s13293-020-00304-9
  8. Hidayati, D. (2020). Profil Penduduk Terkonfirmasi Positif Covid-19 Dan Meninggal: Kasus Indonesia Dan Dki Jakarta. Jurnal Kependudukan Indonesia, 2902, 93. https://doi.org/10.14203/jki.v0i0.541
  9. Keputusan Menteri Kesehatan Republik Indonesia. (2020). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MenKes/413/2020 Tentang Pedoman Pencegahan dan Pengendalian Corona Virus Disease 2019 (Covid-19). MenKes/413/2020, 2019, 207.
  10. Lakoan, M. R., Andayani, T. M., & Chairun, W. (2019). Analisis Kesesuaian Biaya Rill Terhadap Tarif Ina-Cbgs Pada Pengobatan Gagal Jantung Kongestif Pasien Jkn Rawat Inap Rsud Dr. Soehadi Prijonegoro Sragen Tahun 2015. Jurnal Farmasi & Sains Indonesia, 2(2), 1–8.
  11. Lisbet. (2020). Penyebaran covid-19 dan Respons Internasional. Info Singkat, XII(5), 7–12.
  12. Milani, G. P., Macchi, M., & Guz-Mark, A. (2021). Vitamin c in the treatment of covid-19. Nutrients, 13(4), 1–10. https://doi.org/10.3390/nu13041172
  13. Munawaroh, S., Sulistiadi, W., & Rachmad. (2019). Perbedaan Tarif INA–CBG’s Dengan Tarif Riil Rumah Sakit Pada Pasien BPJS Kasus Stroke Iskemik Rawat Inap Kelas I Di RS PON Tahun 2018. Jurnal Manajemen Dan Administrasi Rumah Sakit Indonesia (MARSI), 3(2), 155–165. https://doi.org/https://doi.org/10.52643/marsi.v3i2.532
  14. Nisa, B. I., & Raharjo, B. B. (2018). Determinan Selisih Biaya Riil dan Tarif INA CBG’spada Pasien Jantung Koroner. Higeia Journal of Public Health Research and Development, 1(3), 84–94. https://doi.org/https://doi.org/10.15294/higeia.v5i1.37998
  15. Oksuz, E., Malhan, S., Gonen, M. S., Kutlubay, Z., Keskindemirci, Y., Jarrett, J., Sahin, T., Ozcagli, G., Bilgic, A., Bibilik, M. O., & Tabak, F. (2021). Cost-Effectiveness Analysis of Remdesivir Treatment in Covid-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey. Advances in Therapy, 38(9), 4935–4948. https://doi.org/10.1007/s12325-021-01874-9
  16. Oktadiana, I. (2021). Perbandingan Biaya Riil Pada Pasien Diabetes Mellitus Tipe 2 Dengan Tarif INA-CBG ’ S Di Rumah Sakit Umum Daerah. 2(2), 42–51. https://doi.org/https://doi.org/10.35316/tinctura.v2i2.1547
  17. Pepitasari, B. D., & Anggraini, T. D. (2021). Gambaran Tatalaksana Terapi Pada Pasien Covid-19 Terkonfirmasi di Rumah Sakit X Kota Surakarta Periode Maret – Desember 2020. Journal On Medical Science, 8(2), 119–126.
  18. Pinzón, M. A., Ortiz, S., Holguín, H., Betancur, J. F., Arango, D. C., Laniado, H., Arias, C. A., Munõz, B., Quiceno, J., Jaramillo, D., & Ramirez, Z. (2021). Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia. PLoS ONE, 16(5 May), 1–13. https://doi.org/10.1371/journal.pone.0252057
  19. Rahayu, L. A., Admiyanti, J. C., Khalda, Y. I., Adha, F. R., & Agistany, N. F. F. (2021). Hipertensi, Diabetes Melitus Dan Obesitas Sebagai Faktor Komorbiditas Utama Terhadap Mortalitas Pasien Covid-19 : Sebuah Studi Literatur Tijauan Pustaka Hypertension , Diabetes Mellitus , and Obesity As the Main Comorbidity Factors of Mortality in Covid-1. Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 9, 90–97.
  20. Rahmandani, A., Sarnianto, P., Anggriani, Y., & Purba, F. D. (2021). Analisis Efektivitas Biaya Penggunaan Obat Antivirus Oseltamivir dan Favipiravir pada Pasien Covid-19 Derajat Sedang di Rumah Sakit Sentra Medika Cisalak Depok. Majalah Famasetika, 6(Suppl 1), 133–144.
  21. Satria, R. M. A., Tutupoho, R. V., & Chalidyanto, D. (2020). Analisis Faktor Risiko Kematian dengan Penyakit Komorbid Covid-19. Jurnal Keperawatan Silampari, 4(1), 48–55. https://doi.org/10.31539/jks.v4i1.1587
  22. Setiatin, S. & Y. K. (2020). Telaah Literatur Pelepasan Informasi Medis dan Pengklaiman Biaya Pelayanan Pasien Covid-19 di Rumah Sakit. Jurnal INFOKES, 1(1), 92–103.
  23. Styawan, D. A. (2021). Pandemi Covid-19 Dalam Perspektif Demografi. Seminar Nasional Official Statistics, 2020(1), 182–189. https://doi.org/10.34123/semnasoffstat.v2020i1.716
  24. Sukur, moch halim, Kurniadi, B., Haris, & N Faradillahisari, R. (2020). Penanganan Pelayanan Kesehatan Di Masa Pandemi Covid-19 Dalam Perspektif Hukum Kesehatan. Journal Inicio Legis, 1(1), 1–17.
  25. United Nations. (2020). Policy Brief: The Impact of Covid-19 on older persons. United Nations Sustainable Development Group, 5, 1–16.
  26. Yusa, I. G. P. D. (2020). Dekomposisi Age Profile Pengeluaran Kesehatan Dan Keterkaitannya Dengan Pandemi Covid-19. Seminar Nasional Official Statistics, 1(1), 165–170. https://doi.org/10.34123/semnasoffstat.v2020i1.711